Beacon boost its strength to fight against cancer

Beacon Pharmaceuticals, the largest manufacturer of cancer drugs in Bangladesh, will invest Tk 650 crore to set up a new unit to produce oncology medicines. The demand for cancer drugs in Bangladesh was about tk 500 crore last year and the demand is growing by 15 percent on average a year. Local manufacturers account for 75 percent of the local cancer drug market and the rest is imported. Beacon Pharmaceuticals meets 65 percent of the demand.

In the last eight years, the pharmaceutical company has manufactured more than 50 oncological drugs and 20 more medicines in pipeline. Along with conventional chemotherapy drugs, Beacon manufactures latest oncology products such as monoclonal antibodies, oral targeted therapies and liposomal technology products.

It also makes many of the supportive drugs required for cancer treatment, such as zoledronic acid, filgrastim and Pegfilgrastim injection. After meeting the local demand, Beacon also exports cancer drugs.

To know more https://www.thedailystar.net/business/news/beacon-beef-fight-against-cancer-1633654